| MR编号 | NL/H/1539/002 |
|---|
| 药品名称 | Lamictal Dispers 5 mg, kauw/dispergeerbare tabletten |
|---|
| 活性成分 | |
|---|
| 剂型 | Chewable/dispersible tablet |
|---|
| 上市许可持有人 | GlaxoSmithKline BV
Van Asch van Wijckstraat 55H
3811 LP Amersfoort
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Lithuania (LT)
Lamictal 5 mg disperguojamosios/ kramtomosios tabletės - Hungary (HU)
- Bulgaria (BG)
Lamictal - Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
Lamictal 5 mg comprimate dispersabile/masticabile - Slovakia (SK)
Lamictal 5mg - Slovenia (SI)
- Malta (MT)
- Portugal (PT)
- Estonia (EE)
- Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
Lamictal 5 mg - lösliche Tabletten - France (FR)
- Spain (ES)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
Lamitrin S - Latvia (LV)
Lamictal 5 mg disperģējamās/košļājamās tabletes
|
|---|
| 许可日期 | 2008/09/25 |
|---|
| 最近更新日期 | 2025/06/17 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|